AKT1 and metabolic dysfunction-associated steatotic liver disease: Although there are no reports of WAC affecting NAFLD through the PI3K/AKT signaling pathway, it has been shown that chlorogenic acid prevents HFD-induced hepatic steatosis and may achieve this effect by modulating intestinal flora and increasing GLP-1 secretion (Jiang et al., 2022).